Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03102606
Title Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy (Protective-1)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeyondSpring Pharmaceuticals Inc.
Indications

breast cancer

prostate cancer

lung non-small cell carcinoma

Therapies

Plinabulin

Pegfilgrastim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.